新闻
| PPD Establishes Joint Venture for Drug Discovery of Large Molecules (January 10, 2011) |
| PPD Appoints Andreas Tschirky as Leader of BioDuro (October 21, 2010) PPD, Inc. today announced it has appointed Andreas Tschirky, Ph.D., as leader of BioDuro. In this role, Dr. Tschirky will have responsibility for providing scientific and operational leadership and managing the growth of the Beijing-based drug discovery services company PPD acquired last year. |
| PPD Completes Acquisition of BioDuro (December 03, 2009) PPD has completed its acquisition of BioDuro, capitalizing on the tremendous growth in Asia Pacific. |
| PPD to Acquire BioDuro (November 19, 2009) PPD has signed an agreement to acquire BioDuro, expanding PPD's drug development capabilities in China. |
| Shipping Drug R&D Abroad (October 19, 2009) While major U.S. drug companies have been laying off employees, headcounts at contract pharmaceutical research firms in China – including BioDuro – as well as India and Eastern Europe have surged. |
| CROs Expand Business to Fight Crisis (July 03, 2009) Beijing-based CRO BioDuro and AstraZeneca announced a major deal to expand their research collaboration to optimise discovery research for respiratory and inflammation indications. |
| BioDuro to Work with Roche on Discovery Chemistry (April 8, 2009) Just weeks after expanding its relationship with AstraZeneca, BioDuro has been asked to help with Roche's discovery-phase R&D program. |
| AstraZeneca and BioDuro Expand Discovery Contract (March 25, 2009) BioDuro says AstraZeneca has expanded its relationship with the firm to include the optimization of discovery research operations focused on drugs for respiratory and inflammatory disease. |